Status of arctic charr (Salvelinus alpinus) farming in Norway, Sweden and Iceland

This article describes the status of the Arctic charr (Salvelinus alpinus L.) aquaculture industry in Iceland, Norway and Sweden. The purpose of the work was to give an update on the status of Arctic charr farming in these countries based on information obtained from the industry itself. The data were collected using questionnaires designed for the purpose with key personnel in each country interviewing the farmers or farm managers. The questions were divided on topics focusing on different sides of the production, including farm characteristics, biological challenges and markets. The aim was to identify strengths and weaknesses in the production related to country and production technologies. The information may prove useful for decisions and prioritising future research and development work on removing bottlenecks and improving sustainable production of Arctic charr.     

Aagaardia,a New Holarctic Orthoclad Genus (Diptera: Chironomidae)

Diagnoses of all stages of the new genus Aagaardia are given. The genus includes A. sivertseni (Aagaard), originally described in Eukiefferiella Thienemann, from Norway and Finland and described in all stages; A. protensa sp.n. from Finland and A. triangulata sp.n. from Turkey described as male imagines; and A. longicalcis sp.n. from Canada described in both sexes. The male imagines share bare eyes, strong punctation on wings, bare squama, extended costa, triangular gonostylus and two groups of extremely strong and sclerotized virga. The pupa and the female genitalia show relationship with Paratrissocladius Zav[rcirc]el, while the larva is very similar to the larvae of Psilometriocnemus Sæther and Platysmittia Sæther. Parsimony analyses suggest that Aagaardia forms the plesiomorphic sister genus to the rest of the Heterotrissocladius group combined.     

Limnophyes (Diptera: Chironomidae) from northwestern Russia

The nominal family group taxa of the Ephemeroptera are listed along with their authors, dates of publication and bibliographic references.     

Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines

Radioresistance is a major cause of decreasing the efficiency of radiotherapy for non-small cell lung cancer (NSCLC). To understand the radioresistance mechanisms in NSCLC, we focused on the radiation-induced Notch-1 signaling pathway involved in critical cell fate decisions by modulating cell proliferation. In this study, we investigated the use of Notch-1-regulating flavonoid compounds as novel therapeutic drugs to regulate radiosensitivity in NSCLC cells, NCI-H1299 and NCI-H460, with different levels of radioresistance. Rhamnetin and cirsiliol were selected as candidate Notch-1-regulating radiosensitizers based on the results of assay screening for activity and pharmacological properties. Treatment with rhamnetin or cirsiliol reduced the proliferation of NSCLC cells through the suppression of radiation-induced Notch-1 expression. Indeed, rhamnetin and cirsiliol increased the expression of tumor-suppressive microRNA, miR-34a, in a p53-dependent manner, leading to inhibition of Notch-1 expression. Consequently, reduced Notch-1 expression promoted apoptosis through significant down-regulation of the nuclear factor-κB pathway, resulting in a radiosensitizing effect on NSCLC cells. Irradiation-induced epithelial-mesenchymal transition was also notably attenuated in the presence of rhamnetin and cirsiliol. Moreover, an in vivo xenograft mouse model confirmed the radiosensitizing and epithelial-mesenchymal transition inhibition effects of rhamnetin and cirsiliol we observed in vitro. In these mice, tumor volume was significantly reduced by combinational treatment with irradiation and rhamnetin or cirsiliol compared with irradiation alone. Taken together, our findings provided evidence that rhamnetin and cirsiliol can act as promising radiosensitizers that enhance the radiotherapeutic efficacy by inhibiting radiation-induced Notch-1 signaling associated with radioresistance possibly via miR-34a-mediated pathways.     

Structural and Functional Analysis of the Natural JNK1 Inhibitor Quercetagetin

c-Jun NH2-terminal kinases (JNKs) and phosphatidylinositol 3-kinase (PI3-K) play critical roles in chronic diseases such as cancer, type II diabetes, and obesity. We describe here the binding of quercetagetin (3,3′,4′,5,6,7-hydroxyflavone), related flavonoids, and SP600125 to JNK1 and PI3-K by ATP-competitive and immobilized metal ion affinity-based fluorescence polarization assays and measure the effect of quercetagetin on JNK1 and PI3-K activities. Quercetagetin attenuated the phosphorylation of c-Jun and AKT, suppressed AP-1 and NF-κB promoter activities, and also reduced cell transformation. It attenuated tumor incidence and reduced tumor volumes in a two-stage skin carcinogenesis mouse model.Our crystallographic structure determination data show that quercetagetin binds to the ATP-binding site of JNK1. Notably, the interaction between Lys55, Asp169, and Glu73 of JNK1 and the catechol moiety of quercetagetin reorients the N-terminal lobe of JNK1, thereby improving compatibility of the ligand with its binding site. The results of a theoretical docking study suggest a binding mode of PI3-K with the hydroxyl groups of the catechol moiety forming hydrogen bonds with the side chains of Asp964 and Asp841 in the p110γ catalytic subunit. These interactions could contribute to the high inhibitory activity of quercetagetin against PI3-K. Our study suggests the potential use of quercetagetin in the prevention or therapy of cancer and other chronic diseases.     

Interacting effects of temperature and density on individual growth performance in a wild population of brown trout

相似文献